The Yuan requests your support! Our content will now be available free of charge for all registered subscribers, consistent with our mission to make AI a human commons accessible to all. We are therefore requesting donations from our readers so we may continue bringing you insightful reportage of this awesome technology that is sweeping the world. Donate now
Innovation and Collaboration Take Center Stage at Reuters Pharma Conference 2024
By Oladimeji Ewumi  |  Jun 04, 2024
Innovation and Collaboration Take Center Stage at Reuters Pharma Conference 2024
Image courtesy of and under license from
The Reuters pharma conference is a central platform for pharma executives, patient advocacy groups, and other healthcare experts to share insights, exchange ideas, and be informed about evolving trends within the pharma industry, reports The Yuan contributor Oladimeji Ewumi.

PHILADELPHIA - On March 26th and 27th, 2024, over 1,200 North American visionary pharmaceutical changemakers and leading solution providers converged at the Pennsylvania Convention Center in Philadelphia for the annual Reuters Pharma conference. They led discussions on medical affairs, patient engagement, market access, cell and gene therapy, and real-world evidence (RWE). The primary focus was about driving commercial excellence, achieving deeper integration of patient-first strategies into the pharma industry, and paving the way for a more transformative future for the United States healthcare system.

Kana Hutton, senior project director and head of Reuters Events, North America, delivered the opening remarks, underlining the crucial part of each person in solving problems and forging meaningful connections within the pharma sector. For those wondering what the giant cheetah in the background photos signified, Hutton said, "Healthcare is moving at a fast pace with artificial intelligence (AI), and the friendly-looking cheetah signifies speed." In addition to outpacing this disruption, the focus is on unifying everyone towards a common goal, ensuring no patient is left behind.

Cross-functional collaboration to unlock patient innovation

Hutton kicked off the main event by moderating a session with Maya Martinez-Davis, President of US Commercial at GlaxoSmithKline (GSK), focusing on the desired behaviors of highly collaborative teams - specifically, those that challenge the status quo to reach all patients.

During this session, Hutton asked Martinez-Davis how pharma leaders cultivate trust within their organizations. Martinez-Davis stressed the importance of open communication and areas for improvement to instill confidence and transpare

The content herein is subject to copyright by The Yuan. All rights reserved. The content of the services is owned or licensed to The Yuan. Such content from The Yuan may be shared and reprinted but must clearly identify The Yuan as its original source. Content from a third-party copyright holder identified in the copyright notice contained in such third party’s content appearing in The Yuan must likewise be clearly labeled as such.
Continue reading
Sign up now to read this story for free.
- or -
Continue with Linkedin Continue with Google
Share your thoughts.
The Yuan wants to hear your voice. We welcome your on-topic commentary, critique, and expertise. All comments are moderated for civility.